Ogmentinine® is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below:
- Lower Respiratory Tract Infections: caused by (beta)-lactamase-producing strains of Haemophilus influenzae and Moraxella (Branhamella) catarrhalis.
- Otitis Media: caused by (beta)-lactamase-producing strains of Haemophilus influenzae and Moraxella (Branhamella) catarrhalis.
- Sinusitis: caused by (beta)-lactamase-producing strains of Haemophilus influenzae and Moraxella (Branhamella) catarrhalis.
- Skin and Skin Structure Infections: caused by (beta)-lactamase-producing strains of Staphylococcus aureus, Escherichia coli and Klebsiella spp.
- Urinary Tract Infections: caused by (beta)-lactamase-producing strains of Escherichia coli, Klebsiella spp. and Enterobacter spp.

______________________________________________________________________________________________

Aleppo Pharmaceutical Company (ALPHA) is Syria's leading manufacturer and distributor of pharmaceutical products. Providing high quality products according to GMP requirements; regulations and ISO 9002 (Quality Management System).

Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical manufacturing, pharmaceutical companies, pharmaceutical sales.

If you have any questions about Ogmentinine® that have not been answered on this site send us an email or call ALPHA Pharmaceutical Industry at + 963-21-2122424.

Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria - Ogmentinine®. All rights reserved
Web Design by Syrian Web Solutions